Promoting Resilience in Stress Management (PRISM) for the Reduction of Depression and Anxiety in Young Adults with Cancer or Desmoid Tumor

Inclusion Criteria

• PARTICIPANTS: 18-39 years of age
• PARTICIPANTS: Speak and comprehend English sufficiently to be able to complete study procedures and participate in the program in English * Note: This is a small feasibility study to test PRISM intervention with a new population of interest (young adults with cancer or desmoid tumor with comorbid depressive and/or anxiety symptoms) that has not yet been studied. Further, PRISM intervention has not yet been tested with other languages other than English, though there are trials underway to test adapted PRISM intervention with Spanish-speaking populations (no published data exists yet). In the future, if we find the program feasible and acceptable for our population of interest (young adults with cancer or desmoid tumor with comorbid depressive and/or anxiety symptoms), we will aim to adapt PRISM and expand the intervention to be more inclusive of other languages
• PARTICIPANTS: Have been diagnosed with cancer or desmoid tumor at least 6 or more weeks ago
• PARTICIPANTS: Currently receiving treatment or has completed treatment for cancer or desmoid tumor no more than 6 months ago
• PARTICIPANTS: Score 10-24 (with question #9 not endorsed, or 0) on the Patient Health Questionnaire (PHQ-9) or/and score 10-21 on the Generalized Anxiety Disorder 7-item measure (GAD-7) during the initial screening assessment
• PARTICIPANTS: We will offer remote completion of study visits (i.e., either by phone or video). Patients must have access to a phone (for phone visits) or a computer (for videoconferencing). However, we will also offer in-person visits for anyone who prefers this option
• SUPPORT PERSONS: >= 18 years of age
• SUPPORT PERSONS: A friend or family member invited by the study participant to join the 6th PRISM session

Exclusion Criteria

• PARTICIPANTS: Adults unable to consent, individuals who are not yet adults (age <18), pregnant women, and prisoners
• PARTICIPANTS: Individuals who score < 10 on both PHQ-9 and GAD-7
• PARTICIPANTS: Individuals who are diagnosed with cancer less than 6 weeks at the time of screening (we will be able to approach them again after 6 weeks since diagnosis has passed), or those who completed treatment more than 6 months ago will also be ineligible for this study; they will be offered resources for support, if desired
• PARTICIPANTS: Individuals who report any suicidality (ideation, plan, and/or intent) on PHQ-9 screen (i.e., endorse anything more than 0 for question #9) at the time of the eligibility screening will also be excluded from the current study, and the appropriate safety measures and/or referral to a mental health provider will be made